dc.creator | Peña, Pedro | |
dc.creator | Zagolin, Mónica | |
dc.creator | Acuña, Mónica | |
dc.creator | Navarrete, Sandra | |
dc.creator | Bustamante, Pilar | |
dc.creator | Canals Cifuentes, Andrea | |
dc.date.accessioned | 2019-03-18T11:55:04Z | |
dc.date.available | 2019-03-18T11:55:04Z | |
dc.date.created | 2019-03-18T11:55:04Z | |
dc.date.issued | 2016 | |
dc.identifier | Revista Medica de Chile, Volumen 144, Issue 8, 2018, Pages 965-971 | |
dc.identifier | 07176163 | |
dc.identifier | 00349887 | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/166925 | |
dc.description.abstract | © 2016, Sociedad Medica de Santiago. All right reserved. Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Methods: Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program. Results: The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction l | |
dc.language | en | |
dc.publisher | Sociedad Medica de Santiago | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Revista Medica de Chile | |
dc.subject | Tobacco | |
dc.subject | Tobacco use cessation | |
dc.subject | Tobacco use disorder | |
dc.subject | Varenicline | |
dc.title | Factors associated with success of a smoking cessation program Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario | |
dc.type | Artículo de revista | |